XIAP and breast cancer: A number of XIAP antagonists with nanomolar affinity to the baculovirus IAP repeat 3 (BIR3) domain of XIAP have been described which promote apoptosis in resistance cancer cell lines and inhibit the growth of tumors in a MDA-MB-231 breast cancer mouse xenograft model [81].